| Financial Year |
March 31 2023 |
| Monetary Funds |
5,921,599,529.02 |
| Held-for-trading Financial Assets |
1,146,675.34 |
| Notes Receivable |
-- |
| Accounts Receivable |
265,834,524.61 |
| Advances to Suppliers |
1,047,935,354.69 |
| Other Receivables |
21,656,281.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,826,306,007.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
474,673,189.90 |
| Total Current Assets |
18,559,151,562.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,679,947.25 |
| Investment Properties |
11,881,332,700.14 |
| Fixed Assetes |
1,005,268,310.48 |
| Under-construction Projects |
1,420,529,213.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
262,751,438.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,187,352.30 |
| Deferred Income Tax Assets |
541,497,471.45 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
17,212,269,346.98 |
| Total Assets |
35,771,420,908.98 |
| Short-Term Loans |
3,175,065,472.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,202,973,181.23 |
| Accounts Received In Advance |
146,709,857.83 |
| Employee Compensation Payable |
22,168,289.17 |
| Taxes Payable |
1,272,296,115.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,553,526,642.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
218,715,417.64 |
| Other Current Liabilities |
1,443,471,346.86 |
| Sub-Total of Current Liabilities |
9,430,813,203.69 |
| Long-term Loans |
3,379,720,000.00 |
| Bonds Payable |
3,797,251,333.34 |
| Long-Term Accounts Payable |
1,365,439,826.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
289,338,340.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,150,809,788.40 |
| Total Liabilities |
18,581,622,992.09 |
| Paid-In Capital(Or Share Stock) |
1,122,412,893.00 |
| Capital Surplus |
1,708,961,241.26 |
| Surplus Reserve |
1,571,297,116.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,202,480,951.17 |
| Minority Stockholder's Interest |
2,875,180,422.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,314,617,494.14 |
| Owner's Equity（Stockholder's Equity） |
17,189,797,916.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,771,420,908.98 |
